Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 25, No 22 (August 1), 2007: pp. 3384
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.12.3877

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parmigiani, G.
Right arrow Articles by Chen, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Parmigiani, G.
Right arrow Articles by Chen, S.
Related Articles
Right arrowRelated Correspondence
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

In Reply

Giovanni Parmigiani

Departments of Oncology, Biostatistics, and Pathology, Johns Hopkins University, Baltimore, MD

Sining Chen

Departments of Environmental Health Sciences and Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

We agree with De Bock et al that it is important to further explore whether and how penetrance may vary across clinical populations, and that reliable population-specific risk estimates would have a positive impact on counseling practice. Our study1 is not to belittle the importance of this endeavor, but to provide reasonable compromises to be used in risk assessment while these questions are being addressed.

A possible source of study heterogeneity raised by De Bock et al is a decreasing temporal trend in the estimated penetrances. In Figure 1 in Chen et al,1 we arranged studies chronologically so readers could form an opinion about this issue. The earliest study yielded higher estimates than the remainder in several age strata. Beyond this observation, however, we find it difficult to detect a clear temporal pattern. A recent population-based study by Risch et al2 estimated breast cancer risk of BRCA1 mutation carriers by age 80 at 0.90 (95% CI, 0.77 to 0.97). This further questions the association between risk estimates and year of publication. Similar considerations apply to other sources of heterogeneity examined by the original article, which suggests that we are still at a time when a combined estimate is likely to be useful.

Estimates of the risk of breast cancer for BRCA1 by age 70 range from 0.36 to 0.71. What should a counselor do in the face of this variation? Select one of the estimates according to study characteristics, consider all studies, and present a range or risks, or rely on a compromise? Our software in BayesMendel supports all three options.3 Selecting one of the estimates may open the door to improved tailoring, but may also be prone to errors and arbitrariness. Presenting all estimates has the advantage of being thorough about variation, but the challenge of communicating this variation and properly incorporating it into decision making can be daunting. This leaves a broad range of situations where one size, although it may not fit all, can be currently practical to many.

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The author(s) indicated no potential conflicts of interest.

REFERENCES

1. Chen S, Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329-1333, 2007[Abstract/Free Full Text]

2. Risch HA, McLaughlin JR, Cole DEC, et al: Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694-1706, 2006[Abstract/Free Full Text]

3. Chen S, Wang W, Broman K, et al: BayesMendel: An R environment for Mendelian risk prediction. Stat Appl Genet Mol Biol 3: Article 21, 2004


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Correspondence

  • One Risk Fits All?
    Geertruida H. De Bock, Marian J.E. Mourits, and Jan C. Oosterwijk
    JCO 2007 25: 3383-3384 [Full Text]



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parmigiani, G.
Right arrow Articles by Chen, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Parmigiani, G.
Right arrow Articles by Chen, S.
Related Articles
Right arrowRelated Correspondence
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online